KUCURI LAGI HATIMU
By : ADA BAND
[intro] Em D C 2x
Em D C
gelisah merindukan pelukmu
Em D C
salahku meninggalkanmu oh kasihku
Am D
maafkan salahku dulu
Am D
aku sayang kepadamu
[chorus]
G D Em
andaikan ku curi lagi hatimu
C G D
percayalah hanya padamu cintaku
G D Em
kamulah harta yang paling indah
C G D
ku sayang dan selalu ku jaga kekasih
[int] Em D C
Em D C
selalu membayangkan wajahmu
Em D C
terbawa disetiap waktu dan mimpiku
Am D
maafkan salahku dulu
Am D
aku sayang kepadamu
[chorus]
G D Em
andaikan ku curi lagi hatimu
C G D
percayalah hanya padamu cintaku
G D Em
kamulah harta yang paling indah
C G D
ku sayang dan selalu ku jaga kekasih
C D Em
belahlah dadaku
C D Em
lihat betapa besarnya cinta ini
[solo] C
[chorus]
G D Em
andaikan ku curi lagi hatimu
C G D
percayalah hanya padamu cintaku
G D Em
kamulah harta yang paling indah
C G D
ku sayang dan slalu ku jaga kekasih
G D Em
andaikan ku curi lagi hatimu
C G D
percayalah hanya padamu cintaku
G D Em
kamulah harta yang paling indah
C G D
ku sayang dan selalu ku jaga kekasih
[outro] Em D C 2x Em
It's the Catch-22 of clinical trials: to protect pregnant women and children from the risks of untested drugs....we don't test drugs adequately for them. In the last few decades , we've been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for "vulnerable populations," like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. It got so bad, that by the late 1990s, the FDA realized regulations and more for pregnant women - and women generally - had to change. The NIH (National Institutes of Health) took action too. And so few drugs had enough safety and efficacy information for children that, even in official circles, children were being called "therapeutic orphans." Action began on that, too. There is still a long way to go. But this month there was a sign that ...
Comments
Post a Comment